![]() |
市场调查报告书
商品编码
1292531
全球上肢植入物市场规模、份额、行业趋势分析报告按材料、类型(肩部、肘部、手/腕部)、用途、区域展望和预测,2023-2029Global Upper Extremity Implants Market Size, Share & Industry Trends Analysis Report By Material, By Type (Shoulder, Elbow and Hand & Wrist), By End-use (Hospitals, Clinics and ASCs'), By Regional Outlook and Forecast, 2023 - 2029 |
预计到 2029 年,上肢植入物的市场规模将达到 23 亿美元,预测期内復合年增长率为 6.2%。
根据 KBV 基数矩阵中的分析,DePuy Synthes (Johnson &Johnson) 是该市场的领导者。 2021年10月,DePuy Synthes推出了2.7mm锁骨接骨板系统“可变角度锁定加压接骨板”,用于治疗小、中、大外侧、轴向和内侧锁骨骨折。 该推出的产品提供了一种将锁骨尺寸与患者身高相关联的板形状,符合锁骨的弓形和轮廓,并包括广泛的锁骨解剖变异性。 Medtronic PLC、Stryker Corporation 和 Zimmer Biomet Holdings, Inc. 等公司是该市场的主要创新者。
市场增长因素
运动损伤增加
全年参加某些体育运动是导致伤害增加的一个主要原因,尤其是在年轻人中。 如今,许多运动员选择专攻并专注于一项运动。 因此,如今,即使是轻微的肌肉不平衡和功能障碍也更有可能导致过度使用损伤。 此外,18岁以下的运动员受伤的情况也更多。 即使您正在开展各种预防活动,也可能很难将其付诸实践。 因此,与运动相关的伤害正在增加,特别是在年轻人中,这预计将增加对上肢植入物的需求并支持市场扩张。
老年人口增加
人口老龄化,或者说年龄分布的老龄化,主要出现在高收入国家。 然而,这一趋势对低收入和中等收入国家的影响最大。 例如,在日本,超过60%的人口年龄在30岁以上。 到 2050 年,大多数 60 岁以上的人口预计将生活在低收入和中等收入国家。 由于平均寿命的延长,老龄化社会正在进步。 而老年人更容易出现肌肉和关节相关并发症,可能需要上肢等植入物,预计这将推动市场增长。
市场抑制因素
种植手术后的并发症
所有外科手术都存在一定的风险,而传染性感染的存在可能会加剧这些风险。 感染、失血和脱臼风险是关节置换手术的三大风险。 种植体脱位是当种植体周围的肌肉变弱时(尤其是在治疗后的前三个月)运动不当可能导致的问题。 为了防止这个问题,重要的是避免某些活动,尤其是手术后的前三个月。 这可能会阻碍上肢植入物的市场增长。
输入 Outlook
按类型划分,市场分为肩部、肘部和手/手腕。 肩部部分将在 2022 年市场中占据最高的收入份额。 这是因为,由于运动损伤、肩关节脱位、人口老龄化、骨关节炎病例增加、肩关节骨折等增加,对上肢植入物的产品需求不断增加。 肩关节置换术是最常见的四肢骨科手术之一。
材料展望
按材料分类,生物材料可分为金属生物材料、陶瓷生物材料、高分子生物材料和天然生物材料。 天然生物材料领域在 2022 年市场取得了大幅增长。 天然生物材料在外科手术中普遍存在。 此外,这种生物材料支架或支持物使细胞能够开始构建新组织,从而在预测期内推动该细分市场的增长。
最终使用 Outlook
按最终用途,可分为医院、ASC 和诊所。 ASC 细分市场在 2022 年市场取得了可喜的增长率。 这是由于上肢手术对 ASC 的需求不断增加、新产品不断进步以及 FDA 的批准。 凭藉出色的术后疼痛管理、患者提早出院、副作用更少以及总体成本最小化,ASC 类别为患者带来了额外的好处。 预计这些因素将推动该细分市场的增长。
区域展望
按地区划分,在北美、欧洲、亚太地区和拉美地区进行了分析。 2022 年,北美地区将占据最高的市场收入份额。 这是由于肩部损伤增加,包括骨折、扭伤、拉伤、脱臼和分离等因素造成的。 此外,北美地区重要参与者的存在以及运动损伤的增加正在推动区域扩张。 此外,随着治疗骨折、脱臼、肌腱炎、关节炎等各种疾病的医疗机构的建立,对产品的需求显着增加,推动了该地区的市场增长。
The Global Upper Extremity Implants Market size is expected to reach $2.3 billion by 2029, rising at a market growth of 6.2% CAGR during the forecast period.
Natural Biomaterials is gaining popularity and growing at a faster rate because of its capacity for integrating and modifying as well as their bio-compatibility with the patient's tissue. Therefore, Natural Biomaterials registered $157.8 million revenue in 2022. According to a recent analysis of Global Burden of Disease (GBD) 2019 statistics, 1.71 billion people worldwide are affected by musculoskeletal diseases such as fractures, osteoarthritis, amputation and other injuries, and arthritis. Most affected are 441 million in high-income countries, 427 million in the WHO Western Pacific Region, and 369 million in the WHO South-East Asia Region. In addition, musculoskeletal diseases are the leading cause of YLDs, accounting for more than 149 million YLDs, or 17 percent of all YLDs globally.
The major strategies followed by the market participants are Acquisitions as the key developmental strategy in order to keep pace with the changing demands of end users. For instance, In November, 2020, Stryker acquired Wright Medical Group N.V. to innovate and reach more patients. Additionally, In May, 2023, Zimmer Biomet took over Ossis to build out their partnership and broadening Zimmer Biomet's orthopedic suite with the addition of Ossis' personalized implants. Together with this, Zimmer Biomet Holdings, Inc. acquired Embody, Inc. in February, 2023, to strengthen its growing Sports Medicine suite and supports continued business transformation.
Based on the Analysis presented in the KBV Cardinal matrix; DePuy Synthes (Johnson & Johnson) is the forerunner in the Market. In October, 2021, DePuy Synthes introduced Variable Angle Locking Compression Plate, a 2.7 mm Clavicle Plate System, for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles. The launched product provides plate shapes that show the correlation between clavicle size and patient stature to match the bow and contour of the clavicle and contain a wide range of anatomic variability of the clavicle. Companies such as Medtronic PLC, Stryker Corporation and Zimmer Biomet Holdings, Inc. are some of the key innovators in Market.
Market Growth Factors
The increasing prevalence of sport injuries
The leading cause of the increase in injuries, especially in young people, is the year-round participation in a particular sport. Nowadays, many athletes opt to specialize in and focus on just one sport. So today, a slight muscle imbalance or dysfunction is far more likely to lead to an overuse injury. Also, athletes under the age of 18 are suffering more injuries, even though they engage in various preventative activities, putting it into action could be difficult. Thus, for these reasons, sports-related injuries are becoming more common, particularly in young people, which is predicted to drive up demand and support market expansion.
The growing number of older adults
Population aging, or a country's movement in age distribution toward older ages, has been seen mostly in high-income nations. However, this trend has the biggest influence in low- and middle-income countries. For instance, the population of Japan is over 60% older than the age of 30. Most people over 60 are expected to live in low- and middle-income countries by 2050. An aging population is on the rise due to increased life expectancy. And as older populations are more prone to muscle or joints related complications, which may require implants like upper extremities, implants are expected to drive the market growth.
Market Restraining Factors
Complications following implant surgery
Every surgical operation has some risks; the existence of contagious infections can make these risks worse. The danger of infection, blood effusion, and dislocation are the three main risks associated with joint replacement surgery. Dislocation of the implant is a problem that can happen during an inappropriate movement when the muscles surrounding the implant are too weak (particularly in the first three months following the treatment). Avoiding specific motions is crucial to preventing this problem, especially in the first three months following the operation. This will hinder the market growth for upper extremities implants.
Type Outlook
Based on type, the market is segmented into shoulder, elbow and hand & wrist. The shoulder segment held the highest revenue share in the market in 2022. This is due to the increase in sports injuries, shoulder dislocations, an aging population, a growth in osteoarthritis cases, and shoulder fractures, resulting in a rise in demand for products for implanting the upper extremities. In addition, shoulder replacements rank among the most common orthopedic operations for the extremities.
Material Outlook
On the basis of material, the market is divided into metallic biomaterials, ceramic biomaterials, polymeric biomaterials and natural biomaterials. The natural biomaterials segment procured a considerable growth rate in the market in 2022. Natural biomaterials have become popular in surgical operations. Also, this biomaterial's scaffolding or support enables cells to begin building new tissue, which provides the segment's growth in the forecasted period.
End-Use Outlook
By end-use, the market is classified into hospitals, ASCs' and clinics. The ASCs' segment garnered a promising growth rate in the market in 2022. This is due to increased demand for ASCs in upper-extremities procedures, increased new product advancements, and FDA approval. With excellent postoperative pain management, quick patient discharge, few side effects, and overall cost minimization, the ASCs category offers additional benefits to the patient. The above-mentioned factors are anticipated to drive the market segment's growth.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region generated the highest revenue share in the market in 2022. This is owing to factors like the increase in shoulder injuries, including fractures, sprains, and strains, as well as dislocations and separations. In addition, the presence of important participants in North America and the rise in sports injuries are driving regional expansion. Also, the need for products has grown significantly as a result of the establishment of healthcare facilities that treat a variety of ailments, such as fractures, dislocations, tendonitis, and arthritis, which is fueling the market growth in the region.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, DePuy Synthes (Johnson & Johnson), Zimmer Biomet Holdings, Inc., Smith & Nephew PLC, Medtronic PLC, Aesculap, Inc. (B. Braun Melsungen AG), DJO Global (Enovis Corporation), Ossur Hf., Acumed LLC (Colson Medical, Inc.) and Arthrex, Inc.
Recent Strategies Deployed in Upper Extremity Implants Market
Partnerships, Collaborations and Agreements:
May-2023: Zimmer Biomet took over Ossis, a maker 3D-printed orthopaedic implant. This acquisition would aim to build out their partnership and broadening Zimmer Biomet's orthopedic suite with the addition of Ossis' personalized implants.
Feb-2023: Zimmer Biomet Holdings, Inc. acquired Embody, Inc., a medical device company focused on soft tissue healing. Under this acquisition, Zimmer Biomet strengthens its growing Sports Medicine suite and supports continued business transformation.
Jul-2022: Acumed acquired ExsoMed, a provider of advanced solutions for hand surgery. This acquisition of ExsoMed, whose products support an intramedullary approach to treat hand fractures, increase Acumed's complete suite of upper extremity solutions for easy to complex injuries.
Jan-2021: DJO, LLC completed the acquisition of Trilliant Surgical®, a national provider of foot and ankle orthopedic implants. Following this acquisition, Trilliant Surgical's major product technologies and clinical efficacy supports DJO's focused development into the adjacent high-growth US foot and ankle market.
Jan-2021: Smith+Nephew completed the acquisition of the Extremity Orthopaedics business of Integra LifeSciences Holdings Corporation, a provider of broader and deeper solutions with an extensive soft tissue reconstruction offering. This acquisition would support Smith+Nephew's strategy to invest in higher growth segments. This would notably strengthen Smith+Nephew's extremities business by adding a combination of a focused sales channel, aligning with shoulder replacement and upper and lower extremities suite.
Product Launches and Product Expansions:
Oct-2021: DePuy Synthes introduced Variable Angle Locking Compression Plate, a 2.7 mm Clavicle Plate System, for the treatment of lateral, shaft and medial fractures for small, medium and large clavicles. The launched product provides plate shapes that shows the corelation between clavicle size and patient stature to match the bow and contour of the clavicle and contain a wide range of anatomic variability of the clavicle.
Aug-2021: Johnson & Johnson's DePuy Synthes division announced the launch of the Inhance shoulder system, a fully integrated system that includes both stemmed and stemless implants. The launch enables the surgeon to easily transform from the former to the latter at the time of procedure if required. Additionally, the product is designed to tackle a wide range of cases.
Geographical Expansions:
Jan-2022: Medtronic plc received a Japan's Ministry of Health, Labour and Welfare for the sale and reimbursement approval of the Micra™ AV Transcatheter Pacing System. This approval broadens the number of patients across Japan eligible to receive Micra TPS, the world's smallest pacemaker.
Approvals and Trials:
Aug-2022: Stryker opened a new facility in Ireland. The new high-tech facility is a 156,000-square-foot facility, which would reinforce the company's market position in additive manufacturing.
Market Segments covered in the Report:
By Material
By Type
By End-use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures